Cytomx Therapeutics, Inc.
SEC CIK 1501989 · CTMX · last insider filing 2026-06-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Jones Elaine V | Director | filed 2015 - 2026 |
| Meyers James R | Director | filed 2018 - 2026 |
| Gilbert Halley E | Director | filed 2020 - 2026 |
| Young Matthew P. | Director | filed 2015 - 2026 |
| Mohindru Mani | Director | filed 2020 - 2026 |
| Ashworth Alan | Director | filed 2021 - 2026 |
| Su Zhen | Director | filed 2024 - 2026 |
| Mccarthy Sean A. | Director · President and CEO | filed 2015 - 2026 |
| Gluck Frederick W | Director | filed 2015 - 2022 |
| Scarlett John A | Director | filed 2016 - 2021 |
| Fuchs Charles S. | Director | filed 2017 - 2020 |
| Huh Hoyoung | Director | filed 2015 - 2018 |
| Exter Neil | Director | filed 2015 - 2017 |
| Mccourt Marion | Director | filed 2017 - 2017 |
| Canaan IX L.P. | Director | filed 2015 - 2017 |
| Canaan Partners IX LLC | Director | filed 2015 - 2017 |
| Shannon Timothy M | Director | filed 2015 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Ogden Christopher | See Remarks | filed 2022 - 2026 |
| Chu Yu-Waye | Chief Medical Officer | filed 2023 - 2026 |
| Belvin Marcia | SVP, Chief Scientific Officer | filed 2023 - 2026 |
| Lester Rachael | Chief Business Officer | filed 2025 - 2026 |
| Rowland Lloyd A | General Counsel | filed 2018 - 2025 |
| Landau Jeffrey B | Chief Financial Officer | filed 2022 - 2024 |
| Peterson Amy C. | EVP, Chief Development Officer | filed 2019 - 2023 |
| Campoy Carlos | Chief Financial Officer | filed 2020 - 2023 |
| Hannah Alison L. | Chief Medical Officer | filed 2020 - 2022 |
| Knifsend Robin | Principal Accounting Officer | filed 2019 - 2020 |
| Kavanaugh William Michael | Chief Scientific Officer and | filed 2015 - 2020 |
| Humphrey Rachel | Chief Medical Officer | filed 2015 - 2019 |
| RAY Debanjan | Chief Financial Officer | filed 2017 - 2019 |
| Goeltz II Robert C. | Chief Financial Officer | filed 2015 - 2017 |
| Ladd Cynthia J | Senior VP and General Counsel | filed 2015 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.